HYBRID EVENT: Join us in person in Rome, Italy or attend virtually from anywhere.

5th Edition of International Heart Congress

June 24-26, 2027 | Hybrid Event

June 24 -26, 2027 | Rome, Italy

Valvular Heart Disease

Valvular Heart Disease

Valvular heart disease occurs when one or more of the heart's valves are damaged, affecting the normal flow of blood through the heart. This condition can involve valve stenosis (narrowing of the valve opening) or valve regurgitation (leakage of the valve), both of which can impair heart function over time. Common causes include age-related changes, infections like endocarditis, or congenital defects. Symptoms of valvular heart disease may include fatigue, shortness of breath, and swelling in the legs. Treatment options vary based on the severity of the condition and may include medications to control symptoms or surgical interventions such as valve repair or replacement. Early detection and management are key to preventing more severe complications.

Committee Members
Speaker at International Heart Congress 2027 - Syed Raza

Syed Raza

Awali Hospital, Bahrain
Heart Congress 2027 Speakers
Speaker at International Heart Congress 2027 - Sergey Suchkov

Sergey Suchkov

N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Heart Congress 2027 - Uwe Peter Tigor

Uwe Peter Tigor

Auxilius Pharma, United States
Speaker at International Heart Congress 2027 - Syed Raza

Syed Raza

Awali Hospital, Bahrain

Submit your abstract Today

Watsapp